Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.

Spaeder J, Najjar SS, Gerstenblith G, Hefter G, Kern L, Palmer JG, Gottlieb SH, Kasper EK.

Am Heart J. 2006 Apr;151(4):844.e1-10.

PMID:
16569544
2.

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.

Macdonald PS, Keogh AM, Aboyoun CL, Lund M, Amor R, McCaffrey DJ.

J Am Coll Cardiol. 1999 Mar 15;33(4):924-31.

3.

Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.

Kumar A, Choudhary G, Antonio C, Just V, Jain A, Heaney L, Papp MA.

Am Heart J. 2001 Sep;142(3):512-5.

PMID:
11526366
4.

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.

Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA.

J Card Fail. 1997 Sep;3(3):173-9.

PMID:
9330125
5.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

6.

Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.

Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S.

Am J Cardiovasc Drugs. 2006;6(4):259-63.

PMID:
16913827
7.

Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA; COMET investors.

Eur J Heart Fail. 2005 Jun;7(4):640-9.

8.

Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.

Bajcetic M, Kokic Nikolic A, Djukic M, Kosutic J, Mitrovic J, Mijalkovic D, Jovanovic I, Simeunovic S, Spasic MB, Samardzic R.

Clin Ther. 2008 Apr;30(4):702-14.

PMID:
18498919
9.

Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.

Pamboukian SV, Aminbakhsh A, Thompson CR, Amin H, Mortimer S, D'yachkova Y, Ignaszweski AP.

Clin Transplant. 1999 Oct;13(5):426-31.

PMID:
10515224
10.

[Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].

Kawashiro N, Matsuda N, Endo Y, Uchida Y, Kasanuki H.

J Cardiol. 2006 May;47(5):229-37. Japanese.

PMID:
16764329
11.

Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.

Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.

J Am Coll Cardiol. 2004 Nov 2;44(9):1825-30.

12.

Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.

Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.

Am Heart J. 2000 Apr;139(4):596-608.

PMID:
10740140
13.

Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.

Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.

Pharmacotherapy. 2009 Aug;29(8):883-90. doi: 10.1592/phco.29.8.883.

PMID:
19637941
14.

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.

Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.

J Am Coll Cardiol. 1995 May;25(6):1225-31.

16.

Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.

Franciosa JA, Massie BM, Lukas MA, Nelson JJ, Lottes S, Abraham WT, Fowler M, Gilbert EM, Greenberg B; COHERE Participant Physicians.

Am Heart J. 2004 Oct;148(4):718-26.

PMID:
15459606
17.

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).

Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ; CARMEN investigators and co-ordinators.

Eur J Heart Fail. 2004 Jun;6(4):467-75.

18.

Remote titration of carvedilol for heart failure patients by advanced practice nurses.

Moyer-Knox D, Mueller TM, Vuckovic K, Mischke L, Williams RE.

J Card Fail. 2004 Jun;10(3):219-24.

PMID:
15190531
19.

Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.

Udelson JE, Pressler SJ, Sackner-Bernstein J, Massaro J, Ordronneau P, Lukas MA, Hauptman PJ.

J Card Fail. 2009 Jun;15(5):385-93. doi: 10.1016/j.cardfail.2008.12.010. Epub 2009 Feb 12.

PMID:
19477398
20.

Titration of carvedilol in elderly heart failure patients.

Lawless CE, Tamlyn T, Shah R, Karim FM, Khan E, Creech S.

Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):230-5.

PMID:
16247281

Supplemental Content

Support Center